"Living Your Best Life with Parkinson's Disease," a free community event, will provide an opportunity to hear from experts on empowering the lives of individuals and their families affected by the ...

A new support group for people living with Parkinson’s disease and their caregivers has launched at Bradley Wellness Center, part of Hamilton Medical Center and Vitruvian Health. It meets on the first ...

US-based Bayer subsidiary BlueRock Therapeutics has accelerated bemdaneprocel, its investigational cell therapy candidate for Parkinson’s disease, to Phase III trials after a Phase I study saw the ...

Many people with Parkinson’s disease experience speech and swallowing difficulties that can weaken their voice or make them difficult to understand. Thanks to a grant from the Parkinson Voice Project, ...

Cell and gene therapies account for 20% of pipeline Parkinson's therapy bemdaneprocel in Phase 3 trial Pharma success urgently needed, says fund manager FRANKFURT, Sept 25 (Reuters) - Bayer's ...

Bayer has early evidence that its Parkinson’s disease cell therapy is safe. Now, with a phase 2 clinical trial on course to open enrollment next year, the German drugmaker is set to start showing ...

MeiraGTx has one gene therapy in a potentially pivotal clinical trial for cancer patients and another gene therapy ready to start Phase 3 in Parkinson’s disease. Completing the studies will be ...